IGFBP-3 is the main carrier protein for insulin-like growth factor 1 (IGF-1) and reflects growth hormone production.
IGF-1 bindendes Protein 3 is often considered in the context of tiredness, reduced capacity, brain fog, or chronic exhaustion. This short overview clarifies what the marker can contribute, where its limits are, and when symptom or illness context becomes more important.
IGF-1 bindendes Protein 3 matters when fatigue overlaps with glucose regulation, metabolic strain, or diabetes-related questions. It helps interpret one metabolic pathway, but not every chronic exhaustion pattern.
IGF-1 bindendes Protein 3 does not explain PEM, delayed worsening after activity, unstable day-to-day function, or a wider multisystem pattern on its own. A single lab value can support interpretation, but it cannot replace symptom timing and longitudinal context.
If fatigue persists, exertion is tolerated poorly, or symptoms escalate after activity, the marker should be linked to a broader fatigue, ME/CFS, PEM, or questionnaire context. That usually makes interpretation far more useful than treating the value as a standalone endpoint.
IGF-1 Binding Protein 3 (IGFBP-3) is the most abundant binding protein for insulin-like growth factor 1 (IGF-1) in the blood. It prolongs the half‑life of IGF-1 and regulates its delivery to tissues throughout the body. Because IGFBP-3 production is stimulated by growth hormone, measuring it together with IGF-1 helps evaluate the growth hormone axis, most commonly in children with growth disorders or adults with suspected acromegaly. The levels vary significantly with age and sex.
Low IGFBP-3 may suggest growth hormone deficiency or reduced production of IGF-1. Possible causes include malnutrition, liver disease, or chronic illness. In children, low levels could contribute to poor growth. Because reference ranges are age‑ and sex‑specific, results should be compared to the appropriate norm for the individual.
Elevated IGFBP-3 can be a sign of growth hormone excess, as seen in gigantism in children or acromegaly in adults. It may also occur during pregnancy. Interpretation requires correlation with IGF-1 levels and clinical findings, and should always use age‑ and sex‑matched reference ranges from the testing laboratory.
This result is not specific for ME/CFS or Long COVID. Read it together with the clinical question, symptoms, related findings and the laboratory reference range rather than in isolation.
Practical details are separated from the general FAQ so they are easier to find.
IGF-1 bindendes Protein 3 matters when fatigue overlaps with glucose regulation, metabolic strain, or diabetes-related questions. It helps interpret one metabolic pathway, but not every chronic exhaustion pattern.
If fatigue persists, exertion is tolerated poorly, or symptoms escalate after activity, the marker should be linked to a broader fatigue, ME/CFS, PEM, or questionnaire context. That usually makes interpretation far more useful than treating the value as a standalone endpoint.
You now know which questions can matter when reading this result. With Elara you can keep the value and its surrounding context together over time.
Save the lab value with its date so individual measurements do not get lost.
See previous measurements together instead of relying on a single snapshot.
View IGF-1 Binding Protein 3 (IGFBP-3) alongside symptom, energy, sleep and PEM entries without assuming one caused the other.
Export your history as a PDF — structured for the next check-up.
IGFBP-3 is the main protein that carries insulin-like growth factor 1 (IGF-1) in the blood. It helps control how much IGF-1 reaches body tissues and reflects growth hormone activity.
A low IGFBP-3 level may indicate growth hormone deficiency, poor nutrition, or a condition that reduces IGF-1 production. In children, it might be associated with growth issues. Your doctor will interpret it together with IGF-1 and other tests.
Normal IGFBP-3 levels depend on your age and sex. For adults, a typical range is around 2–4 mg/L (2,000–4,000 µg/L), but ranges vary by lab. Children have different ranges that change as they grow. Always refer to your lab’s reference range.
IGF-1 bindendes Protein 3 does not explain PEM, delayed worsening after activity, unstable day-to-day function, or a wider multisystem pattern on its own. A single lab value can support interpretation, but it cannot replace symptom timing and longitudinal context.
This biomarker gains value when it is connected to symptom patterns, daily function, and structured self-observation instead of being read in isolation.
Reduced capacity, multisystem symptoms, and delayed worsening often make more sense when the broader ME/CFS pattern is considered.
Markers linked to sleep, stress, recovery, hormones, or metabolism often become more useful when viewed through pacing and daily load management.
Questionnaires help connect biomarkers to symptom patterns, functional limits, and patient-reported change over time.
Markers from the same system can add useful context when a single lab value is hard to interpret on its own.
No individual medical review is documented.
This English content was created with AI assistance and automatically validated. This is not an individual medical review.
This information does not replace medical advice. Lab values should be assessed in the context of your medical history, the reason for testing and other findings. Elara provides health information for orientation — not diagnoses or treatment decisions.
Bring your lab values, symptoms and energy into one shared context — so you walk into your next appointment more informed and structured.
